Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 20/20 | 0.51 |
| ▸ | MAP3K6 | O95382 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21469736 | 0.79 | MAP3K5 (0.48) | MAP3K5 | |
| SCHEMBL19258658 | 0.75 | MAP3K5 (0.64) | MAP3K5MAP3K6 | |
| SCHEMBL18027903 | 0.74 | MAP3K5 (0.65) | MAP3K5MAP3K6 | |
| SCHEMBL21469775 | 0.73 | MAP3K5 (0.66) | MAP3K5MAP3K6 | |
| SCHEMBL15143877 | 0.72 | MAP3K5 (0.65) | MAP3K5MAP3K6 | |
| SCHEMBL20672236 | 0.71 | MAP3K5 (0.64) | MAP3K5MAP3K6 | |
| Hydrochloric Acid SCHEMBL15136406 | 0.71 | MAP3K5 (0.64) | MAP3K5MAP3K6 | |
| Water SCHEMBL30634013 | 0.71 | MAP3K5 (0.64) | MAP3K5MAP3K6 | |
| SCHEMBL17880575 | 0.71 | MAP3K5 (0.64) | MAP3K5MAP3K6 | |
| Water SCHEMBL28514353 | 0.71 | MAP3K5 (0.64) | MAP3K5MAP3K6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919911-B2 | Tricyclic ASK1 inhibitors | Terns, Inc. (US) | 2021-02-16 | — | — | US | disclosed |
| US-20190315767-A1 | TRICYCLIC ASK1 INHIBITORS | Terns, Inc. (US) | 2019-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919911-B2 | Tricyclic ASK1 inhibitors | MAP3K1, MAP3K8, MAP3K20 | MAP3K5 12/4885MAP3K6 15/4885 |
| US-20190315767-A1 | TRICYCLIC ASK1 INHIBITORS | MAP3K1, MAP3K8, MAP3K20 | MAP3K5 12/4885MAP3K6 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.